<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">68571</article-id><article-id pub-id-type="doi">10.7554/eLife.68571</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-231199"><name><surname>Shan</surname><given-names>Zhao</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5064-1023</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232356"><name><surname>Li</surname><given-names>Leike</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232357"><name><surname>Atkins</surname><given-names>Constance Lynn</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232358"><name><surname>Wang</surname><given-names>Meng</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232359"><name><surname>Wen</surname><given-names>Yankai</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8144-1515</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232366"><name><surname>Jeong</surname><given-names>Jongmin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232367"><name><surname>Moreno</surname><given-names>Nicolas F</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232368"><name><surname>Feng</surname><given-names>Dechun</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232369"><name><surname>Gui</surname><given-names>Xun</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210206"><name><surname>Zhang</surname><given-names>Ningyan</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215295"><name><surname>Lee</surname><given-names>Chun Geun</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15766"><name><surname>Elias</surname><given-names>Jack A</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232370"><name><surname>Lee</surname><given-names>William M</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152062"><name><surname>Gao</surname><given-names>Bin</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232371"><name><surname>Lam</surname><given-names>Fong Wilson</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-18611"><name><surname>An</surname><given-names>Zhiqiang</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9309-2335</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-232372"><name><surname>Ju</surname><given-names>Cynthia</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1640-7169</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">School of Life Science</institution>, <institution>Yunnan University</institution>, <addr-line><named-content content-type="city">Kunming</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">Texas Therapeutics Institute</institution>, <institution>UTHealth McGovern Medical School</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Anesthesiology</institution>, <institution>UTHealth McGovern Medical School</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Laboratory of Liver Disease</institution>, <institution>National Institute on Alcohol Abuse and Alcoholism</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Texas Therapeutics Institute</institution>, <institution>Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Molecular Microbiology and Immunology</institution>, <institution>Brown University</institution>, <addr-line><named-content content-type="city">Providence</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Internal Medicine</institution>, <institution>University of Texas Southwestern Med School</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Division of Pediatric Critical Care Medicine</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">University of Texas Health Science Center at Houston</institution>, <institution>Brown Foundation Institute of Molecular Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-109584"><name><surname>Noble</surname><given-names>Paul W</given-names></name><role>Reviewing editor</role><aff><institution>Cedars-Sinai Medical Centre</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>zhiqiang.an@uth.tmc.edu</email> (ZA);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>Changqing.Ju@uth.tmc.edu</email> (CJ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>10</day><month>06</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e68571</elocation-id><history><date date-type="received"><day>19</day><month>03</month><year>2021</year></date><date date-type="accepted"><day>02</day><month>06</month><year>2021</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-68571-v1.pdf"/><abstract><p><bold>Background: </bold>Hepatic platelet accumulation contributes to acetaminophen (APAP)-induced liver injury (AILI). However, little is known about the molecular pathways involved in platelet recruitment to the liver and whether targeting such pathways could attenuate AILI.</p><p><bold>Methods:</bold> Mice were fasted overnight before <italic>i.p. </italic>injected with APAP at a dose of 210 mg/kg for male mice and 325 mg/kg for female mice. Platelets adherent to Kupffer cells were determined in both mice and patients overdosed with APAP. The impact of Î±-Chi3l1 on alleviation of AILI was determined in a therapeutic setting, and liver injury was analyzed. </p><p><bold>Results: </bold>The present study unveiled a critical role of chitinase 3-like-1 (Chi3l1) in hepatic platelet recruitment during AILI. Increased Chi3l1 and platelets in the liver were observed in patients and mice overdosed with APAP. Compared to wild-type (WT) mice, <italic>Chil1</italic><sup>-/-</sup> mice developed attenuated AILI with markedly reduced hepatic platelet accumulation. Mechanistic studies revealed that Chi3l1 signaled through CD44 on macrophages to induce podoplanin expression, which mediated platelet recruitment through C-type lectin-like receptor 2. Moreover, APAP treatment of <italic>Cd44</italic><sup>-/- </sup>mice resulted in much lower numbers of hepatic platelets and liver injury than WT mice, a phenotype similar to that in <italic>Chil1</italic><sup>-/-</sup> mice. Recombinant Chi3l1 could restore hepatic platelet accumulation and AILI in <italic>Chil1</italic><sup>-/-</sup> mice, but not in <italic>Cd44</italic><sup>-/- </sup>mice. Importantly, we generated anti-Chi3l1 monoclonal antibodies and demonstrated that they could effectively inhibit hepatic platelet accumulation and AILI.</p><p><bold>Conclusions: </bold>we uncovered the Chi3l1/CD44 axis as a critical pathway mediating APAP-induced hepatic platelet recruitment and tissue injury. We demonstrated the feasibility and potential of targeting Chi3l1 to treat AILI.</p><p><bold> Funding:</bold> ZS received funding from NSFC (32071129). FWL received funding from NIH (GM123261). ALFSG received funding from NIDDK (DK 058369). ZA received funding from CPRIT (RP150551 and RP190561) and the Welch Foundation (AU-0042-20030616). C.J. received funding from NIH (DK122708, DK109574, DK121330, and DK122796) and support from a University of Texas System Translational STARs award. Portions of this work was supported with resources and the use of facilities of the Michael E. DeBakey VA Medical Center and funding from Department of Veterans Affairs I01 BX002551 (Equipment, Personnel, Supplies). The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>32071129</award-id><principal-award-recipient><name><surname>Shan</surname><given-names>Zhao</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM123261</award-id><principal-award-recipient><name><surname>Lam</surname><given-names>Fong Wilson</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK122708,DK109574,DK121330,and DK122796</award-id><principal-award-recipient><name><surname>Ju</surname><given-names>Cynthia</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>DK 058369</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>William M</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004917</institution-id><institution>Cancer Prevention and Research Institute of Texas</institution></institution-wrap></funding-source><award-id>RP150551 and RP190561</award-id><principal-award-recipient><name><surname>An</surname><given-names>Zhiqiang</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000928</institution-id><institution>Welch Foundation</institution></institution-wrap></funding-source><award-id>AU-0042-20030616</award-id><principal-award-recipient><name><surname>An</surname><given-names>Zhiqiang</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animal studies described have been approved by the UTHealth Institutional Animal Care and Use Committee (IACUC AWC-20-0074)</p></fn><fn fn-type="other"><p>Human subjects: Serum samples from patients diagnosed with APAP-induced liver failure on day 1 of admission were obtained from the biobank of the Acute Liver Failure Study Group (ALFSG) at UT Southwestern Medical Center, Dallas, TX, USA. The study was designed and carried out in accordance with the principles of ALFSG and approved by the Ethics Committee of ALFSG (HSC-MC-19-0084). Formalin-fixed, paraffin-embedded human liver biopsies from patients diagnosed with APAP-induced liver failure were obtained from the National Institutes of Health-funded Liver Tissue Cell Distribution System at the University of Minnesota, which was funded by NIH contract # HHSN276201200017C.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Intravital microscopy videos can be reached via the following links: https://bcm.box.com/s/15hmtryyrdl302mihrsm034ure87x4ea (Supplemental video 1, PBS treatment) and https://bcm.box.com/s/tuljfmstvv4lvoksx16fkxkpirkekynz (Supplemental Video 2, APAP treatment)(n=6-7 mice/group, 4-15 videos/mouse).</p></sec><supplementary-material><ext-link xlink:href="elife-68571-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>